ANRO

Alto Neuroscience (ANRO)

About Alto Neuroscience (ANRO)

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Details

Daily high

$20.46

Daily low

$19.41

Price at open

$19.77

52 Week High

$25.17

52 Week Low

$1.60

Market cap

639.5M

Dividend yield

0.00%

Volume

167,502

Avg. volume

289,010

P/E ratio

-8.92

Alto Neuroscience News